Development Roadmap
From candidate to clinic.
Our preclinical roadmap moves a single, well-validated candidate through the studies needed to support a clinical filing — with clear go/no-go criteria at each stage.
Candidate Selection
Complete
Lead therapeutic candidate identified and prioritized against disease-relevant criteria.
In Vitro Validation
In Progress
Functional validation in disease-relevant human cell systems is underway.
In Vivo Proof of Concept
Planned
Demonstration of efficacy in a translational disease model.
IND-Enabling Studies
Planned
Toxicology, pharmacology, and manufacturing readiness work supporting regulatory filing.
First-in-Human
Planned
Early clinical evaluation in patients with endometriosis.
Candidate Selection
Complete
Lead therapeutic candidate identified and prioritized against disease-relevant criteria.
In Vitro Validation
In Progress
Functional validation in disease-relevant human cell systems is underway.
In Vivo Proof of Concept
Planned
Demonstration of efficacy in a translational disease model.
IND-Enabling Studies
Planned
Toxicology, pharmacology, and manufacturing readiness work supporting regulatory filing.
First-in-Human
Planned
Early clinical evaluation in patients with endometriosis.
Confidential preclinical study designs and regulatory plans are shared with qualified investors under CDA.